|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 39 studies with search of: | Open Studies | "Cytomegalovirus Infections" |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
gB/MF59 Vaccine in Preventing Cytomegalovirus Infection in Healthy Adolescent Females
|
||||
| 2 | Recruiting |
Genotyping of Cytomegalovirus From Patients in Israel
|
||||
| 3 | Recruiting |
Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections
|
||||
| 4 | Recruiting |
Cytomegalovirus Cell-Mediated Immunity
|
||||
| 5 | Recruiting |
Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients
|
||||
| 6 | Recruiting |
Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy
|
||||
| 7 | Recruiting |
Artesunate in Preemptive Treatment of Human Cytomegalovirus (CMV) in Stem Cell Transplant Recipients
|
||||
| 8 | Not yet recruiting |
Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection
|
||||
| 9 | Recruiting |
Trial of Donor T Cells Sensitized With Pentadecapeptides of the CMV-PP65 Protein for the Treatment of Cytomegalovirus (CMV) Infections Following Allogeneic Hematopoietic Stem Cell Transplants
|
||||
| 10 | Recruiting |
Determining a Viral Load Threshold for Treating Cytomegalovirus (CMV)
|
||||
| 11 | Recruiting |
Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients
|
||||
| 12 | Not yet recruiting |
Cytomegalovirus (CMV) Infection in Amniotic Fluid
|
||||
| 13 | Recruiting |
Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation
|
||||
| 14 | Recruiting |
Prospective Multicentric Study of Cytomegalovirus Resistance in Transplant Patients and Bone Marrow Recipients
|
||||
| 15 | Recruiting |
CMV Glycoprotein B Vaccine in Allograft Recipients
|
||||
| 16 | Not yet recruiting |
Dose-escalation Study of the Safety, Tolerability and Ability of CMX001 to Prevent or Control Cytomegalovirus (CMV) Infection in R+ Hematopoietic Stem Cell Transplant Recipients
|
||||
| 17 | Recruiting |
Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant
|
||||
| 18 | Recruiting |
Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer
|
||||
| 19 | Recruiting |
Safety, Toxicity and Maximum Tolerated Dose (MTD) of One Intravenous IV Injection of Donor Cytotoxic T-Lymphocytes (CTLs) Specific for Cytomegalovirus (CMV) and Adenovirus
|
||||
| 20 | Recruiting |
Effect of Burn Size on Cytomegalovirus Reactivation and Correlates of T Cell Immune Function in Burned Patients
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-39) |
|